Mississauga, Canada

Julie Lynn Lukkarila

This inventor holds 1 USPTO granted patent. Top assignee: University of Toronto. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie Lynn Lukkarila. Retrieved from https://idiyas.com/inventor/julie-lynn-lukkarila

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julie Lynn Lukkarila: Innovator in UBA5 Inhibitors

Introduction

Julie Lynn Lukkarila is a prominent inventor based in Mississauga, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of UBA5 inhibitors. Her work is crucial in advancing therapeutic options for various diseases.

Latest Patents

Julie holds one patent related to UBA5 inhibitors. The patent describes compounds of the Formula (I), which are designed to inhibit the UBA5 enzyme. This innovation has the potential to impact the treatment of conditions associated with UBA5 activity.

Career Highlights

Julie is affiliated with the University of Toronto, where she conducts her research and development. Her academic background and expertise have positioned her as a key figure in her field.

Collaborations

Some of her notable coworkers include Patrick Thomas Gunning and Sara R Da Silva. Their collaborative efforts contribute to the advancement of research in biochemistry and related areas.

Conclusion

Julie Lynn Lukkarila is an influential inventor whose work on UBA5 inhibitors showcases her dedication to scientific innovation. Her contributions are paving the way for future advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…